SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aquapharm Chemicals Pvt. Ltd. - (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Chemicals | Small Cap | Aquapharm Chem-Amalg Share Price

BSE Share Price
Not Listed

Aquapharm Chemicals Pvt. Ltd. - (Amalgamated)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Chemicals | Small Cap | Aquapharm Chem-Amalg Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹0
TTM Sales
₹575 Cr.
Book Value per Share
-
P/E Ratio
0.00
Industry PE
52.7
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.00
EV/EBITDA
0.00
Dividend Yield
INF%
Profitability Efficiency
Return on Equity (ROE)
3.49%
Return on Capital Employed (ROCE)
6.89%
Return on Assets (ROA)
2.46%
Operating Profit Margin
5.9%
Net Profit Margin
3.36%
Gross Profit Margin
7.8%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-26.97%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-77.34%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-84.54%
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
₹330 Cr.
Equity
₹0 Cr.
Face Value
-
All Time Low / High
- / -

Aquapharm Chemicals Pvt. . - (Amalgamated) stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 21.2%19%18.6%12.7%21%18.4%14.1%36.7%24.6%6.9%-

Growth Parameters

Sales 4344444304505755916111,0571,043761575
Sales YoY Gr.-2.4%-3.3%4.7%27.8%2.7%3.4%73.1%-1.4%-27%-
Adj EPS 1,200.51,253.71,405.5998.32,390.22,777.32,317.69,294.37,032.9921.30
YoY Gr.-4.4%12.1%-29%139.4%16.2%-16.6%301%-24.3%-86.9%-
BVPS (₹) 6,6537,252.98,884.210,092.412,71315,604.117,930.527,313.333,965.935,112.50
Adj Net
Profit
3637.639.427.262.572.658.721914919.6NAN
Cash Flow from Ops. 51.367.853.95.233.739.972.5-49.6369158-
Debt/CF from Ops. 3.32.4335.166.53.6-7.80.80.2-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 6.4%5.8%7.6%-27%
Adj EPS -2.9%-17.4%-26.5%-86.9%
BVPS20.3%22.5%25.1%3.4%
Share Price - - - -

Key Financial Parameters

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
20.11816.910.420.619.613.639.921.92.70
Op. Profit
Mgn %
13.715.815.611.216.517.115.127.419.25.9NAN
Net Profit
Mgn %
8.38.59.26.110.912.39.620.714.32.6NAN
Debt to
Equity
0.90.80.70.70.60.60.60.60.40-
Working Cap
Days
1541461541661661962131962232210
Cash Conv.
Cycle
938787981011031071161391400

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales434.22444.47429.76449.94574.94590.65610.701,0571,042.59761.45
Operating Expenses + 374.65374.49362.67399.67479.82489.64518.48768.02843.15716.26
Manufacturing Costs17.6957.0957.0223.0827.4930.3531.8941.584645.13
Material Costs274.15227.91216.19277.36356.27348.35368.86526.83590.49455.25
Employee Cost 31.6633.9940.3338.9245.5452.0652.30100.9651.2655.53
Other Costs 51.1655.4949.1360.3250.5358.8765.4398.65155.40160.34
Operating Profit 59.5669.9867.1050.2795.12101.0292.22288.98199.4445.19
Operating Profit Margin (%) 13.7%15.7%15.6%11.2%16.5%17.1%15.1%27.3%19.1%5.9%
Other Income + 16.339.2115.2615.2320.1520.9119.8748.5868.7236.89
Exceptional Items 0000000000
Interest 7.0810.597.5310.619.4215.4515.5719.6326.0322.44
Depreciation 5.537.828.5710.4310.9411.2914.3316.9118.3820.90
Profit Before Tax 63.2860.7966.2644.4694.9195.1982.20301.02223.7538.75
Tax 19.3020.9320.3214.6625.4518.8722.9677.1958.2713.17
Profit After Tax 43.9839.8645.9429.8069.4576.3259.24223.83165.4925.58
PAT Margin (%) 10.1%9.0%10.7%6.6%12.1%12.9%9.7%21.2%15.9%3.4%
Adjusted EPS (₹)1,466.01,328.71,640.61,093.52,657.12,919.82,338.19,497.67,799.71,205.4
Dividend Payout Ratio (%)17.10%33.90%0%0%0%0.50%0.80%0.60%0.90%4.60%

Valuation of Aquapharm Chem-Amalg - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund + 199.59217.59248.76275.02332.29407.86454.32643.69720.65744.98
Share Capital 332.802.732.612.612.532.362.122.12
Reserves 196.59214.59245.96272.29329.68405.25451.79641.34718.53742.86
Debt +161.28154.37151.90169.90190.67248.82251.47344.59271.1829.18
Long Term Debt27.6021.7925.7417.3120.3032.3387.4145.6413.850
Short Term Debt133.69132.58126.16152.59170.36216.50164.06298.95257.3429.18
Minority Interest0000000000
Trade Payables36.5640.0451.8443.9250.8864.7386.02139.2160.3985.10
Others Liabilities 45.6446.0254.8057.9865.9048.4860.34144.50116.0150.97
Total Liabilities 443.07458.02507.29546.82639.74769.90852.151,2721,168.24910.23

Fixed Assets

Net Fixed Assets +121.45129.26161.21159.58154.74184.13223.28246.48293.90276.35
Gross Block185.15199.89239.81248254.09290.65342.14380.50445.20442.82
Accumulated Depreciation63.7070.6378.6088.4299.35106.52118.86134.02151.30166.46
CWIP 1.452.440.491.0410.3930.279.3310.1635.51112.50
Investments 77.64106.70122.36128.56151.85161.64214.69207.56231.9148.44
Inventories66.0657.8173.01104.13108.34103.95131.14295.99189.48154.26
Trade Receivables96.72102.67100.2497.28131.22143.69164.73379.36232.23198.81
Cash Equivalents 56.4039.4230.5326.4031.4351.2434.9043.5696.0961.97
Others Assets 23.3619.7219.4629.8251.7694.9874.0888.8989.1357.90
Total Assets 443.07458.02507.29546.82639.74769.90852.151,2721,168.24910.23

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity + 51.2667.8253.915.2033.6639.9372.51-49.62368.79157.94
PBT 63.2860.7966.2644.4694.9195.1982.20301.02223.7538.75
Adjustment -11.0510.54-2.375.30-9.675.2829.2919.0722.8266.07
Changes in Working Capital 5.87-0.76-2.16-55.25-75.32-35.51-21.42-289.6178.6772.51
Tax Paid -13.91-13.34-15.3410.6923.75-25.02-17.56-80.11-56.46-19.38
Cash Flow From Investing Activity + -81.97-41.87-48.557.49-31.69-73.18-70.634.07-116.2582.45
Capex -54.66-16.37-38.3413.85-19.22-58.82-27.51115.89-86.16-94.39
Net Investments -38.75-29.06-15.65-9.60-15.44-1-45.18000
Others 11.443.575.443.232.96-13.362.06-111.82-30.09176.84
Cash Flow From Financing Activity + 27.66-42.93-14.27-16.823.0635.39-20.0770.81-219.83-275.92
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid -7.08-10.59-7.53-10.61-9.42-13.91-12.50-14.66-27.48-21.46
Dividend Paid -9-15000.27-0.47-0.38-0.46-1.41-1.17
Others 43.75-17.35-6.74-6.2112.2149.78-7.1985.93-190.93-253.29
Net Cash Flow -3.04-16.98-8.91-4.135.042.14-18.1925.2632.71-35.53

Financial Ratio

PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)24.5319.1119.711.3822.8720.6213.7440.7724.263.49
ROCE (%)21.1719.0418.6312.6721.0318.4314.1336.7124.596.89
Asset Turnover Ratio1.111.020.920.880.970.840.7510.850.73
PAT to CFO Conversion(x)1.171.71.170.170.480.521.22-0.222.236.17
Working Capital Days
Receivable Days78.4079.5083.9077.3072.5084.9092.2093.90107.10103.30
Inventory Days57.2049.4054.1069.4067.5065.6070.3073.808582.40
Payable Days51.4061.3077.606348.6060.6074.607861.7058.30

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Aquapharm Chemicals Pvt. Ltd. - (Amalgamated) FAQs

The current trading price of Aquapharm Chem-Amalg on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Aquapharm Chem-Amalg stood at ₹0.00 Cr

The latest P/E ratio of Aquapharm Chem-Amalg as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Aquapharm Chem-Amalg as of 31-Dec-1969 is 0.00.

The 52-week high of Aquapharm Chem-Amalg is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aquapharm Chem-Amalg is ₹575 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Aquapharm Chemicals Pvt. Ltd. - (Amalgamated)

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: